Doege-Potter Syndrome: A Presumptive Case of Metastatic Hemangiopericytoma with Persistent Hypoglycemia in a 27-Year-Old Male
DOI:
https://doi.org/10.15605/jafes.036.01.16Keywords:
Doege-Potter syndrome, hemangioperictyoma, hypoglycemiaAbstract
Doege-Potter syndrome (DPS) is a rare paraneoplastic condition characterized by hypoinsulinemic hypoglycemia from a solitary fibrous tumor. The underlying mechanism is the secretion of a prohormone form of insulin-like growth factor II (IGF-II) by the tumor, which causes decreased release of glucose into the circulation. We report the case of a 27-year-old Filipino male with presumptive DPS from a recurrent right temporo-zygomatic hemangiopericytoma (HPC). The complexity of DPS requires a multidisciplinary approach. Early screening for metastases from HPC may prevent the undesirable sequelae of the disease process.
Downloads
References
Kim DW, Na KJ, Yun JS, Song SY. Doege-Potter syndrome: A report of a histologically benign but clinically malignant case. J Cardiothorac Surg. 2017;12(1):64. https://www.ncbi.nlm.nih.gov/pubmed/28784156. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547527. https://doi.org/10.1186/s13019-017-0630-4.
Schutt RC, Gordon TA, Bhabhra R, et al. Doege-Potter Syndrome presenting with hypoinsulinemic hypoglycemia in a patient with malignant extrapleural solitary fibrous tumor: A case report. J Med Case Rep. 2013;7:11. https://www.ncbi.nlm.nih.gov/pubmed/23302323. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546898. https://doi.org/10.1186/1752-1947-7-11.
Bi X, Zhai J, Chun CD. Solitary fibrous tumor of the abdominal wall resurfacing as unilateral pleural effusion and mass: A case report and review of the literature. Respir Med Case Rep. 2018;23:4-7. https://www.ncbi.nlm.nih.gov/pubmed/29159031. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683803. https://doi.org/10.1016/j.rmcr.2017.10.013.
Jameson JL, Kasper DL, Longo DL, Fauci AS, Hauser SL, Loscalzo J, eds. Harrison's Principles of Internal Medicine. 20th ed. Columbus, Ohio: McGraw-Hill Education, 2018.
Faulhaber GAM, Borges FK, Ascoli AM, Seligman R, Furlanetto TW. Adrenal failure due to adrenal metastasis of lung cancer: A case report. Case Rep Oncol Med. 2011;2011:326815.
https://www.ncbi.nlm.nih.gov/pubmed/22606443. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350132. https://doi.org/10.1155/2011/326815.
Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709-28. https://www.ncbi.nlm.nih.gov/pubmed/19088155. https://doi.org/10.1210/jc.2008-1410.
Dutta P, Aggarwal A, Gogate Y, et al. Non-islet cell tumor-induced hypoglycemia: A report of five cases and brief review of the literature. Endocrinol Diabetes Metab Case Rep. 2013;2013:130046. https://www.ncbi.nlm.nih.gov/pubmed/24616774. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922193. https://doi.org/10.1530/EDM-13-0046.
Daughaday WH, Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet cell tumors. Proc Natl Acad Sci USA. 1989;86(17):6778-82. https://www.ncbi.nlm.nih.gov/pubmed/2771956. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297929. https://doi.org/10.1073/pnas.86.17.6778.
Stout AP, Murray MR. Hemangiopericytoma: A vascular tumor featuring Zimmermann's pericytes. Ann Surg. 1942;116(1):26-33. https://www.ncbi.nlm.nih.gov/pubmed/17858068. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1543753. https://doi.org/10.1097/00000658-194207000-00004.
Koch M, Nielsen GP, Yoon SS. Malignant tumors of blood vessels: Angiosarcomas, hemangioendotheliomas, and hemangioperictyomas. J Surg Oncol. 2008;97(4):321-9.
https://www.ncbi.nlm.nih.gov/pubmed/18286475. https://doi.org/10.1002/jso.20973.
Hendrick L, Angel W, Besh S, O’Brien T, Goins N, Dickson P. Multidisciplinary management of metastatic hemangiopericytoma presenting with hypoglycemia. Ann Hematol Oncol. 2017; 4(3):1140.
Penel N, Amela EY, Decanter G, Robin YM, Marec-Berard P. Solitary fibrous tumors and so-called hemangiopericytoma. Sarcoma. 2012;2012:690251. https://www.ncbi.nlm.nih.gov/pubmed/22566753. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337510. https://doi.org/10.1155/2012/690251.
Robinson LA. Solitary fibrous tumor of the pleura. Cancer Control. 2006;13(4):264-9.
https://www.ncbi.nlm.nih.gov/pubmed/17075563. https://doi.org/10.1177/107327480601300403.
Vallat-Decouvelaere AV, Dry SM, Fletcher CD. Atypical and malignant solitary fibrous tumors in extrathoracic locations: Evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998;22(12):1501-11. https://www.ncbi.nlm.nih.gov/pubmed/9850176. https://doi.org/10.1097/00000478-199812000-00007.
Espat NJ, Lewis JJ, Leung D, et al. Conventional hemangiopericytoma: Modern analysis of outcome. Cancer. 2002;95(8):1746-51. https://www.ncbi.nlm.nih.gov/pubmed/12365023. https://doi.org/10.1002/cncr.10867.
Ng VY, Scharschmidt TJ, Mayerson JL. Solitary fibrous tumor. 2019. https://emedicine.medscape.com/article/1255879-overview#a4.
Chen LF, Yang Y, Yu XG, Gui QP, Xu BN, Zhou DB. Multimodal treatment and management strategies for intracranial hemangiopericytoma. J Clin Neurosci. 2015;22(4):718-25. https://www.ncbi.nlm.nih.gov/pubmed/25744076. https://doi.org/10.1016/j.jocn.2014.11.011.
Wu R. Solitary fibrous tumor. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/lungtumorsolitaryfibroustumor.html. Accessed 27 February 2021.
Geramizadeh B, Marzban M, Churg A. Role of immunohistochemistry in the diagnosis of solitary fibrous tumor, a review. Iran J Pathol. 2016;11(3):195-203.
https://www.ncbi.nlm.nih.gov/pubmed/27799967. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079451.
England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13(8):640-58. https://www.ncbi.nlm.nih.gov/pubmed/2665534. https://doi.org/10.1097/00000478-198908000-00003.
Kalebi AY, Hale MJ, Wong ML, Hoffman T, Murray J. Surgically cured hypoglycemia secondary to pleural solitary fibrous tumour: Case report and update review on the Doege-Potter syndrome. J Cardiothorac Surg. 2009;4:45.
https://www.ncbi.nlm.nih.gov/pubmed/19689813. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739517. https://doi.org/10.1186/1749-8090-4-45.
Roy TM, Burns MV, Overly DJ, Curd BT. Solitary fibrous tumor of the pleura with hypoglycemia: The Doege-Potter syndrome. J Ky Med Assoc. 1992;90(11): 557-60.
https://www.ncbi.nlm.nih.gov/pubmed/1474302.
Chamberlain MH, Taggart DP. Solitary fibrous tumor associated with hypoglycemia: An example of the Doege-Potter syndrome. J Thorac Cardiovasc Surg. 2000;119(1):185-7.
https://www.ncbi.nlm.nih.gov/pubmed/10612786. https://doi.org/10.1016/s0022-5223(00)70242-x.
Davda R, Seddon BM. Mechanisms and management of non-islet cell tumour hypoglycaemia in gastrointestinal stromal tumour: Case report and a review of published studies. Clin Oncol (R Coll Radiol). 2007;19(4):265-8.
https://www.ncbi.nlm.nih.gov/pubmed/17433971. https://doi.org/10.1016/j.clon.2006.12.008.
Sohda T, Yun K. Insulin-like growth factor II expression in primary meningeal hemangiopericytoma and its metastasis to the liver accompanied by hypoglycemia. Hum Pathol. 1996;27(8):858-61. https://www.ncbi.nlm.nih.gov/pubmed/8760024. https://doi.org/10.1016/s0046-8177(96)90463-3.
Strâmbu IR, Leonte DG, Bolca CN. Large pleural tumor revealed by severe hypoglycemia: Doege-Potter syndrome. Rom J Morphol Embryol. 2017;58(1):287-91.
https://www.ncbi.nlm.nih.gov/pubmed/28523334.
Holt RI, Teale JD, Jones JS, Quin JD, McGregor AM, Miell JP. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia. Growth Horm IGF Res. 1998;8(6):447-54.
https://www.ncbi.nlm.nih.gov/pubmed/10985756. https://doi.org/10.1016/s1096-6374(98)80297-9.
Trivedi N, Mithal A, Sharma AK, et al. Non-islet cell tumour induced hypoglycaemia with acromegaloid facial and acral swelling. Clin Endocrinol (Oxf). 1995;42(4):433-5.
https://www.ncbi.nlm.nih.gov/pubmed/7750199. https://doi.org/10.1111/j.1365-2265.1995.tb02654.x.
Teale JD, Wark G. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia. Clin Endocrinol (Oxf). 2004;60(4):457-60.
https://www.ncbi.nlm.nih.gov/pubmed/15049960. https://doi.org/10.1111/j.1365-2265.2004.01989.x.
Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: A clinical review. J Clin Endocrinol Metab. 2014;99(3):713-22.
https://www.ncbi.nlm.nih.gov/pubmed/24423303. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393479. https://doi.org/10.1210/jc.2013-3382.
Han G, Zhang Z, Shen X, et al. Doege-Potter syndrome: A review of the literature including a new case report. Medicine (Baltimore). 2017;96(27):e7417.
https://www.ncbi.nlm.nih.gov/pubmed/28682900. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502173. https://doi.org/10.1097/MD.0000000000007417.
Park MS, Patel SR, Ludwig JA, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. 2011;117(21):4939-47.
https://www.ncbi.nlm.nih.gov/pubmed/21480200. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135685. NIHMSID: NIHMS277775. https://doi.org/10.1002/cncr.26098.
Lee ATJ, Benson C. Pazopanib as a choice for advanced solitary fibrous tumour. Lancet Oncol. 2020;21(3):332-3. https://www.ncbi.nlm.nih.gov/pubmed/32066545. https://doi.org/10.1016/S1470-2045(20)30018-8.
Martin-Broto J, Cruz J, Penel N, et al. Pazopanib for treatment of typical solitary fibrous tumours: A multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020;21(3):456-66.
https://www.ncbi.nlm.nih.gov/pubmed/32066540. https://doi.org/10.1016/S1470-2045(19)30826-5.
Martin-Broto J, Stacchiotti S, Lopez-Pousa A, et.al. Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: A multicentre, single-arm, phase 2 trial. Lancet Oncol. 2019;20(1):134-44. https://www.ncbi.nlm.nih.gov/pubmed/30578023. https://doi.org/10.1016/S1470-2045(18)30676-4.
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.